Functional constipation is a prevalent issue in pediatrics, characterized by infrequent or difficult bowel movements without an underlying organic cause. It’s crucial for healthcare professionals to accurately diagnose and manage this condition, distinguishing it from other potential etiologies. This article provides a comprehensive overview of the differential diagnosis of constipation in children, enhancing understanding for effective clinical practice.
Clinicians must recognize the multifactorial nature of functional constipation, considering factors like diet, environment, psychological stress, and toilet training practices. While functional constipation accounts for the majority of pediatric cases, organic causes, though less common (approximately 5%), need to be systematically excluded. This review aims to refine the diagnostic approach to pediatric constipation, ensuring that both functional and organic causes are appropriately considered and managed, thereby improving patient care.
Objectives:
- To identify key indicators that necessitate a differential diagnosis for constipation in pediatric patients.
- To differentiate functional constipation from constipation arising from organic disorders in children.
- To utilize a systematic approach in evaluating pediatric constipation, incorporating history, physical examination, and selective investigations to arrive at an accurate diagnosis.
- To understand the role of interprofessional collaboration in managing the complexities of pediatric constipation and its differential diagnosis.
Introduction
Constipation in children is a widespread concern, affecting approximately 3% of children globally.^1^ In the vast majority (up to 95%) of cases, constipation is functional, meaning it occurs without any identifiable organic disease. Functional constipation is particularly common in children over one year old, especially preschoolers.^2^
The definition of functional constipation centers around deviations from normal bowel habits. This includes infrequent bowel movements, difficulty or pain during defecation, hard stools, and a sensation of incomplete evacuation. While numerous factors can contribute to functional constipation, including dietary habits, stress, and inadequate social support, it is defined by the absence of an underlying organic pathology.
Etiology of Functional Constipation
Functional constipation, particularly common in toilet-training toddlers, often arises from a cycle of stool withholding. While some children may have a predisposition to constipation, certain triggers frequently initiate this cycle.^3^
- Painful Defecation: A single instance of painful bowel movement is often the primary trigger, leading to stool retention and the development of functional constipation.
- Age-Related Factors:
- Toddlers: Dietary transitions, such as moving from breast milk to formula or cow’s milk, can result in harder stools, potentially causing anal fissures and pain. Similarly, pressure during toilet training or a child’s resistance can contribute to constipation.
- Older Children: Factors such as uncomfortable or unfamiliar toilet facilities (e.g., at school), experiences of sexual abuse, perianal trauma, or voluntary stool withholding during play can all initiate or exacerbate constipation.
Epidemiology of Pediatric Constipation
The prevalence of functional constipation varies geographically. European studies report prevalence rates between 0.7% and 12% in children. In North and South America, the range is broader, from 10% to 23%, encompassing infants to adolescents. Asian prevalence figures range considerably, from 0.5% to 29.6%.^4^ These variations highlight the influence of environmental, dietary, and cultural factors on bowel habits and the diagnosis of constipation.
Pathophysiology of Functional Constipation
Stool retention is the central pathophysiological mechanism in functional constipation.^5^ When a child withholds stool, fecal matter accumulates in the colon. The colon’s primary function includes water absorption; as stool remains longer in the colon, more water is absorbed, leading to harder, drier stools that are more difficult to pass. This stool accumulation also stretches the colonic smooth muscles, reducing their effectiveness in propelling stool forward.
This creates a negative feedback loop: stool withholding leads to harder stools, which are then more painful to pass, further reinforcing stool retention. Chronic stool retention can result in rectal distention and a decreased sensation of rectal fullness, contributing to encopresis, where liquid stool leaks around a fecal impaction.
History and Physical Examination in Diagnosing Constipation
Diagnosis of functional constipation is primarily clinical, based on a detailed history and physical examination. The history should encompass stool frequency, consistency, associated symptoms, and symptom duration. Parents may describe stools as small and pebble-like or infrequent, large stools. A history of rectal bleeding, particularly with hard stools, suggests anal fissures.
It’s important to inquire about systemic symptoms like weakness, abdominal pain, vomiting, or urinary issues, as these may suggest organic etiologies. Lower extremity weakness should prompt consideration of neurological causes. While abdominal pain, vomiting, enuresis, and encopresis can occur in functional constipation, they warrant careful evaluation to rule out organic pathology. Past medical history should explore neurological conditions, surgeries, or chronic illnesses such as hypothyroidism, Hirschsprung disease, and cystic fibrosis. Social history should consider factors like potential lead exposure.^6^
A thorough physical examination is essential. This includes assessing growth parameters and vital signs. Signs of hypothyroidism, such as exophthalmos or thyroid abnormalities, should be noted. Abdominal examination may reveal a palpable fecal mass, indicative of impaction. Abdominal distention or masses should be carefully assessed, and significant abdominal pain should raise suspicion for acute abdominal conditions like appendicitis.
A detailed back examination, especially of the lumbar region, is crucial to identify midline defects, hair tufts, hemangiomas, or dimples, which could indicate spinal dysraphism. The anus should be examined for patency and normal positioning. While not always necessary, a rectal exam can confirm fecal impaction, rule out presacral masses, and assess rectal tone. Neurological assessment of lower extremity strength, reflexes, sensation, and muscle mass is also important.^2^
Diagnostic Criteria: Rome IV
The Rome IV criteria provide standardized diagnostic guidelines for functional constipation in children, distinguishing between infants/toddlers and older children.^7^
Infants and Toddlers (0-4 years):
Diagnosis requires at least two of the following for at least one month, or fewer than two defecations per week:
- History of excessive stool retention
- History of painful or hard bowel movements
- History of large-diameter stools
- Palpable fecal mass in the rectum
For toilet-trained children in this age group, additional criteria include:
- At least one episode of fecal incontinence per week after toilet training is established.
- History of large stools that may obstruct the toilet.
Children Older Than 4 Years:
Diagnosis requires at least two of the following, occurring at least once per week for at least one month, with insufficient criteria for irritable bowel syndrome:
- Two or fewer toilet defecations per week in a child at least 4 years old.
- At least one episode of fecal incontinence per week.
- Retentive posturing or excessive voluntary stool retention.
- Painful or hard bowel movements.
- Palpable fecal mass in the rectum.
- History of large stools obstructing the toilet.
Crucially, these criteria must be met after appropriate evaluation has excluded organic causes for the symptoms.
For children meeting the criteria for functional constipation based on history and examination, extensive testing is often unnecessary. However, in cases of treatment resistance, atypical presentation, or concerning physical exam findings, further investigation or specialist referral may be warranted. Thyroid-stimulating hormone (TSH) testing can screen for hypothyroidism, and lead levels may be relevant in specific contexts. Hirschsprung disease must always be considered, particularly in young children or in cases of persistent or atypical constipation. Contrast enemas and rectal biopsies are diagnostic tools for Hirschsprung disease.^8^
Imaging studies are not routinely required for diagnosing functional constipation but may be useful to exclude other suspected conditions.^9^, ^10^, ^11^, ^12^ Abdominal X-rays can detect fecal impaction, especially when abdominal examination is challenging, but are not routinely indicated.
Treatment and Management Strategies
Disimpaction:
The initial step in treating functional constipation is disimpaction, the removal of accumulated hard stool from the colon. This allows the colon to return to its normal size and function. Historically, methods included manual evacuation, suppositories, and enemas. Options range from glycerin and saline enemas to milk and molasses enemas, and more recently, olive oil enemas.^13^
However, in outpatient pediatric practice, polyethylene glycol (PEG 3350) has become the preferred first-line treatment for disimpaction due to its effectiveness, safety, and tolerability. Dosage recommendations vary, but a common approach is 1 to 1.5 g/kg of PEG 3350 mixed in 6-8 ounces of water or juice, administered over 3 hours. Higher doses may be used in inpatient settings. If initial treatment is ineffective, the dose can be repeated the following day. Lack of response after two days, significant abdominal pain, or persistent vomiting necessitate further evaluation.^14^
Maintenance Therapy:
The second phase focuses on maintaining soft stools to prevent re-accumulation of hard stool as the colon recovers. This phase typically involves oral medications.^11^
- Osmotic Laxatives: PEG 3350 (0.2-0.8 g/kg/day), lactulose (1-3 mL/kg/day), magnesium hydroxide (0.5-3 mL/kg/day).
- Stool Softeners: Docusate sodium (5 mg/kg/day), mineral oil (1-3 mL/kg/day).
- Stimulant Laxatives (for rescue therapy or adjunct use, short-term): Senna (2.5-7.5 mL/day), bisacodyl (5-10 mg/day).
Nonpharmacological Interventions:
Adequate fiber and fluid intake, along with regular physical activity, are recommended. There is no strong evidence to support routine use of intensive behavioral therapy or biofeedback beyond conventional treatment. Similarly, the efficacy of prebiotics or probiotics in treating constipation is not well-established.^15^
Toilet-trained children should be encouraged to sit on the toilet for 5-10 minutes daily after a meal to leverage the gastrocolic reflex and establish a regular bowel movement routine. Follow-up appointments within 1-3 weeks are crucial to assess treatment effectiveness and adjust the care plan as needed.
Differential Diagnosis: Organic Causes of Constipation
While functional constipation is the most common cause, a thorough differential diagnosis must consider organic etiologies (approximately 5% of cases). These include:
1. Anatomic Abnormalities:
- Anal Atresia: Congenital absence or closure of the anal opening. Usually diagnosed in the newborn period.
- Presacral Masses: Tumors or cysts in the presacral space that can obstruct the rectum.
2. Metabolic and Endocrine Disorders:
- Hypothyroidism: Decreased thyroid hormone can slow bowel motility.
- Cystic Fibrosis: Thickened intestinal secretions can lead to constipation.
- Lead Intoxication: Lead poisoning can affect gastrointestinal function.
3. Neurologic Conditions:
- Hirschsprung Disease: Congenital absence of ganglion cells in the colon, leading to impaired bowel motility. Typically presents in infancy with delayed meconium passage.
- Myelomeningocele (Spina Bifida): Neural tube defect affecting bowel and bladder function.
4. Toxic Ingestions and Medications:
- Botulism: Toxin (e.g., from honey in infants) can cause constipation and other neurological symptoms.
- Opiates: Medications like opioids are well-known to cause constipation.
5. Irritable Bowel Syndrome (IBS):
- In older children and adolescents, IBS with constipation should be considered, although functional constipation and IBS are distinct diagnoses.
Red Flags for Organic Constipation:
Certain clinical features should raise suspicion for an underlying organic disorder and prompt further investigation:
- Systemic Symptoms: Fever, abdominal distention, weight loss or poor weight gain, decreased appetite, bloody diarrhea.
- Early Onset: Constipation starting before 1 month of age.
- Delayed Meconium Passage: Failure to pass meconium within 48 hours of birth.
- Failure to Thrive: Poor growth and development.
- Intermittent Diarrhea and Explosive Stools: May indicate overflow incontinence but can also be seen in certain organic conditions.
- Abnormal Neurological Examination: Hypotonia, absent cremasteric reflex, decreased lower extremity reflexes.
- Lack of Treatment Response: Constipation that does not improve with standard functional constipation management.
In most cases, a detailed history and physical examination will effectively rule out organic causes. However, lower extremity weakness, loss of bladder control, young age (<1 year), poor growth, or lack of treatment response necessitate further investigation. Physical examination should focus on abdominal and neurological assessments, including spinal examination for neural tube defect signs and anorectal examination. Growth curves should be reviewed for growth faltering.^10^
Pertinent Studies and Emerging Therapies
Research continues to explore new treatments for constipation. Lubiprostone, a chloride channel activator, is FDA-approved for adults with constipation but not yet for children.^16^ Prucalopride, a prokinetic agent, has shown promise in adults but is also not currently recommended for pediatric use.^16^
Prognosis of Functional Constipation
With appropriate management, the prognosis for functional constipation is generally good. As children develop regular bowel habits, the frequency of scheduled toilet visits and laxative use can be gradually reduced. Laxative doses are tapered to maintain 1-2 soft bowel movements daily and prevent fecal incontinence.^17^
Recurrent impaction or persistent fecal incontinence suggest treatment failure, requiring a review of the management plan and adherence. Inadequate medication dosage or premature discontinuation are common reasons for treatment failure. Among children referred to pediatric gastroenterologists, approximately 50% achieve full resolution (3+ bowel movements per week without incontinence and off laxatives) within 6-12 months. Another 10% improve but require ongoing laxative therapy, and about 40% continue to experience symptoms despite treatment.^2^
Complications of Untreated Constipation
While typically not life-threatening, untreated functional constipation can lead to complications:
- Anal Fissures: Painful tears in the anal mucosa, often causing rectal bleeding.
- Rectal Prolapse: Protrusion of the rectal lining through the anus.
- Hemorrhoids: Swollen veins in the rectum and anus.
- Encopresis: Fecal incontinence due to stool impaction and overflow.
Postoperative and Rehabilitation Considerations
In cases of persistent constipation despite maximal medical therapy, re-evaluation and further investigations are needed.^2^ Anorectal manometry and balloon expulsion testing can assess for dyssynergic defecation (pelvic floor muscle incoordination) and internal anal sphincter (IAS) achalasia. Botulinum toxin injection may be considered for children with refractory idiopathic chronic constipation unresponsive to conventional treatments like laxatives or biofeedback.^18^
Deterrence and Patient Education
Preventing and managing pediatric functional constipation relies heavily on patient and family education. This includes dietary advice (fiber-rich diet), promoting healthy toilet habits, and addressing psychosocial factors. Early identification of risk factors and proactive intervention are key.
Pearls, Disposition, Pitfalls, and Prevention Strategies
Pearls: Accurate diagnosis hinges on recognizing typical functional constipation symptoms, excluding organic causes, and considering multifactorial contributors. Tailored treatment plans, including diet and behavioral strategies, are essential.
Disposition: Management is often multidisciplinary, involving pediatricians, gastroenterologists, dietitians, and psychologists. Regular follow-up is crucial for monitoring progress and adjusting therapy.
Pitfalls: Common errors include overlooking dietary factors, inadequate education, neglecting behavioral and lifestyle aspects, and failure to consider organic etiologies. Solely relying on medication is often insufficient.
Prevention: Emphasize balanced diets, healthy toilet training, and stress management. Early intervention and an interprofessional approach support long-term prevention.
Healthcare professionals must understand these key aspects for holistic, patient-centered care, improving outcomes and quality of life for children with constipation.
Enhancing Healthcare Team Outcomes
Optimal management of functional constipation necessitates an interprofessional team approach. Family involvement, clear communication, and coordinated care are essential.
- Family Education: Provide written treatment plans at the initial visit, reviewed at each subsequent visit, including instructions for initial management, maintenance, relapse management, and follow-up.
- Treatment Plan Components: Lifestyle modifications (increased activity, fluids, fiber), behavioral interventions (scheduled toilet sitting), and scheduled follow-up appointments (initially every 3-4 weeks, then 3-6 months).
- Nursing Role: Nurses should be familiar with constipation plans, accessible in patient charts, and able to address family questions.
- Pharmacist Role: Pharmacists monitor medication effectiveness and complications, provide patient counseling, and communicate concerns to prescribers.
Interprofessional collaboration ensures comprehensive care and improved outcomes through shared expertise and family empowerment.
Review Questions
(Note: Review questions from the original article are omitted as per instructions)
References
[^1^]: van den Berg MM, Benninga MA, Di Lorenzo C. Epidemiology of childhood constipation: a systematic review. Am J Gastroenterol. 2006 Oct;101(10):2401-9. PubMed: 17032205
[^2^]: Tabbers MM, DiLorenzo C, Berger MY, Faure C, Langendam MW, Nurko S, Staiano A, Vandenplas Y, Benninga MA., European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. North American Society for Pediatric Gastroenterology. Evaluation and treatment of functional constipation in infants and children: evidence-based recommendations from ESPGHAN and NASPGHAN. J Pediatr Gastroenterol Nutr. 2014 Feb;58(2):258-74. PubMed: 24345831
[^3^]: Rajindrajith S, Devanarayana NM, Thapar N, Benninga MA. Myths and misconceptions about childhood constipation. Eur J Pediatr. 2023 Apr;182(4):1447-1458. PubMed: 36689003
[^4^]: Mugie SM, Benninga MA, Di Lorenzo C. Epidemiology of constipation in children and adults: a systematic review. Best Pract Res Clin Gastroenterol. 2011 Feb;25(1):3-18. PubMed: 21382575
[^5^]: Rajindrajith S, Devanarayana NM. Constipation in children: novel insight into epidemiology, pathophysiology and management. J Neurogastroenterol Motil. 2011 Jan;17(1):35-47. PMC free article: PMC3042216 PubMed: 21369490
[^6^]: Saleem M, Butt J, Shaukat Z, Hashim I, Moeezah, Majeed F, Kamran M, Saleem U. Functional outcome of Hirschsprung’s disease in children: A single center study at The Children’s Hospital Lahore. Pediatr Surg Int. 2023 Apr 11;39(1):176. PubMed: 37039898
[^7^]: Zeevenhooven J, Koppen IJ, Benninga MA. The New Rome IV Criteria for Functional Gastrointestinal Disorders in Infants and Toddlers. Pediatr Gastroenterol Hepatol Nutr. 2017 Mar;20(1):1-13. PMC free article: PMC5385301 PubMed: 28401050
[^8^]: Tambucci R, Quitadamo P, Thapar N, Zenzeri L, Caldaro T, Staiano A, Verrotti A, Borrelli O. Diagnostic Tests in Pediatric Constipation. J Pediatr Gastroenterol Nutr. 2018 Apr;66(4):e89-e98. PubMed: 29287015
[^9^]: Trajanovska M, King SK, Gibb S, Goldfeld S. Children who soil: A review of the assessment and management of faecal incontinence. J Paediatr Child Health. 2018 Oct;54(10):1136-1141. PubMed: 30294989
[^10^]: Kearney R, Edwards T, Bradford M, Klein E. Emergency Provider Use of Plain Radiographs in the Evaluation of Pediatric Constipation. Pediatr Emerg Care. 2019 Sep;35(9):624-629. PubMed: 30045349
[^11^]: Constipation Guideline Committee of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. Evaluation and treatment of constipation in infants and children: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr. 2006 Sep;43(3):e1-13. PubMed: 16954945
[^12^]: Beinvogl B, Sabharwal S, McSweeney M, Nurko S. Are We Using Abdominal Radiographs Appropriately in the Management of Pediatric Constipation? J Pediatr. 2017 Dec;191:179-183. PubMed: 29173303
[^13^]: Yokoi A, Kamata N. The usefulness of olive oil enema in children with severe chronic constipation. J Pediatr Surg. 2021 Jul;56(7):1141-1144. PubMed: 33812657
[^14^]: Jarzebicka D, Sieczkowska-Golub J, Kierkus J, Czubkowski P, Kowalczuk-Kryston M, Pelc M, Lebensztejn D, Korczowski B, Socha P, Oracz G. PEG 3350 Versus Lactulose for Treatment of Functional Constipation in Children: Randomized Study. J Pediatr Gastroenterol Nutr. 2019 Mar;68(3):318-324. PubMed: 30383579
[^15^]: Santucci NR, Chogle A, Leiby A, Mascarenhas M, Borlack RE, Lee A, Perez M, Russell A, Yeh AM. Non-pharmacologic approach to pediatric constipation. Complement Ther Med. 2021 Jun;59:102711. PubMed: 33737146
[^16^]: Lang L. The Food and Drug Administration approves lubiprostone for irritable bowel syndrome with constipation. Gastroenterology. 2008 Jul;135(1):7. PubMed: 18541153
[^17^]: Loening-Baucke V. Encopresis. Curr Opin Pediatr. 2002 Oct;14(5):570-5. PubMed: 12352250
[^18^]: Halleran DR, Lu PL, Ahmad H, Paradiso MM, Lehmkuhl H, Akers A, Hallagan A, Bali N, Vaz K, Yacob D, Di Lorenzo C, Levitt MA, Wood RJ. Anal sphincter botulinum toxin injection in children with functional anorectal and colonic disorders: A large institutional study and review of the literature focusing on complications. J Pediatr Surg. 2019 Nov;54(11):2305-2310. PubMed: 31060739
(Note: Disclosures from the original article are omitted as per instructions)
